| Literature DB >> 18438547 |
João Roberto de Sá1, Adriano Miziara Gonzalez, Cláudio Santiago Melaragno, David Saitovich, Denise Reis Franco, Erika Bevilaqua Rangel, Irene Lourdes Noronha, José Osmar Medina Pestana, Marcelo Casaccia Bertoluci, Marcelo Linhares, Marcelo Perosa de Miranda, Patricia Monteagudo, Tércio Genzini, Freddy Goldberg Eliaschewitz.
Abstract
Pancreas and kidney transplants have specific indications, benefits and risks. The procedure has become more common and more often as long-term success has improved and risks have decreased. Compared with a patient being on dialysis, simultaneous pancreas-kidney transplant offers a distinct advantage when it comes to mortality, quality of life and diabetic complications. Since there can be a living-donor kidney transplant,, a possibly similar patient and graft survival by 10 years follow-up, this procedure should be considered. Pancreas after kidney transplants, when successful, can improve microvascular complications compared with kidney transplant alone, but immediate mortality may be higher. Solitary pancreas transplantation can improve the quality of life in selected patients, but it may also increase the immediate risk of mortality due to the complexity of the surgery and the risks of immunosupression. The results of Islet transplantation differ from the higher metabolic performance achieved by whole pancreas allotransplantation and its applicability is limited to selected adult diabetic patients.Entities:
Mesh:
Year: 2008 PMID: 18438547 DOI: 10.1590/s0004-27302008000200024
Source DB: PubMed Journal: Arq Bras Endocrinol Metabol ISSN: 0004-2730